Literature DB >> 33446553

GPER1 is required to protect fetal health from maternal inflammation.

Alfred T Harding1, Marisa A Goff2, Heather M Froggatt1, Jean K Lim2, Nicholas S Heaton3,4.   

Abstract

Type I interferon (IFN) signaling in fetal tissues causes developmental abnormalities and fetal demise. Although pathogens that infect fetal tissues can induce birth defects through the local production of type I IFN, it remains unknown why systemic IFN generated during maternal infections only rarely causes fetal developmental defects. Here, we report that activation of the guanine nucleotide-binding protein-coupled estrogen receptor 1 (GPER1) during pregnancy is both necessary and sufficient to suppress IFN signaling and does so disproportionately in reproductive and fetal tissues. Inactivation of GPER1 in mice halted fetal development and promoted fetal demise, but only in the context of maternal inflammation. Thus, GPER1 is a central regulator of IFN signaling during pregnancy that allows dynamic antiviral responses in maternal tissues while also preserving fetal health.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33446553      PMCID: PMC8060949          DOI: 10.1126/science.aba9001

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

Review 2.  Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.

Authors:  Laura J Yockey; Akiko Iwasaki
Journal:  Immunity       Date:  2018-09-18       Impact factor: 31.745

3.  Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells.

Authors:  P Thomas; Y Pang; E J Filardo; J Dong
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

4.  Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus Infection.

Authors:  Avraham Bayer; Nicholas J Lennemann; Yingshi Ouyang; John C Bramley; Stefanie Morosky; Ernesto Torres De Azeved Marques; Sara Cherry; Yoel Sadovsky; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2016-04-05       Impact factor: 21.023

5.  A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.

Authors:  Craig Hansen; Sheila Desai; Christine Bredfeldt; Craig Cheetham; Mia Gallagher; De-Kun Li; Marsha A Raebel; Karen Riedlinger; David K Shay; Mark Thompson; Robert L Davis
Journal:  J Infect Dis       Date:  2012-08-02       Impact factor: 5.226

Review 6.  TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.

Authors:  Barbara J Stegmann; J Christopher Carey
Journal:  Curr Womens Health Rep       Date:  2002-08

7.  An Immunocompetent Mouse Model of Zika Virus Infection.

Authors:  Matthew J Gorman; Elizabeth A Caine; Konstantin Zaitsev; Matthew C Begley; James Weger-Lucarelli; Melissa B Uccellini; Shashank Tripathi; Juliet Morrison; Boyd L Yount; Kenneth H Dinnon; Claudia Rückert; Michael C Young; Zhe Zhu; Shelly J Robertson; Kristin L McNally; Jing Ye; Bin Cao; Indira U Mysorekar; Gregory D Ebel; Ralph S Baric; Sonja M Best; Maxim N Artyomov; Adolfo Garcia-Sastre; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2018-05-09       Impact factor: 21.023

8.  Local and Systemic Immune Responses to Influenza A Virus Infection in Pneumonia and Encephalitis Mouse Models.

Authors:  Yoshiharu Nagaoka; Nobuyuki Nosaka; Mutsuko Yamada; Masato Yashiro; Yosuke Washio; Kenji Baba; Tsuneo Morishima; Hirokazu Tsukahara
Journal:  Dis Markers       Date:  2017-08-24       Impact factor: 3.434

9.  Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells.

Authors:  M Nakano; T Fujii; M Hashimoto; N Yukawa; H Yoshifuji; K Ohmura; A Nakaizumi; T Mimori
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

10.  Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice.

Authors:  Michael A Pazos; Thomas A Kraus; César Muñoz-Fontela; Thomas M Moran
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

View more
  8 in total

Review 1.  The Interface of Nuclear and Membrane Steroid Signaling.

Authors:  Lindsey S Treviño; Daniel A Gorelick
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

2.  Moderately pathogenic maternal influenza A virus infection disrupts placental integrity but spares the fetal brain.

Authors:  Adrienne M Antonson; Adam D Kenney; Helen J Chen; Kara N Corps; Jacob S Yount; Tamar L Gur
Journal:  Brain Behav Immun       Date:  2021-05-12       Impact factor: 19.227

Review 3.  Nonrespiratory sites of influenza-associated disease: mechanisms and experimental systems for continued study.

Authors:  Heather M Froggatt; Nicholas S Heaton
Journal:  FEBS J       Date:  2022-02-07       Impact factor: 5.622

Review 4.  The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection.

Authors:  Alfred T Harding; Nicholas S Heaton
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

Review 5.  Epigenetic regulation and T-cell responses in endometriosis - something other than autoimmunity.

Authors:  Dariusz Szukiewicz
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

6.  Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia.

Authors:  Eugenio Morelli; Zachary R Hunter; Mariateresa Fulciniti; Annamaria Gullà; Ida Daniela Perrotta; Valeria Zuccalà; Cinzia Federico; Giada Juli; Martina Manzoni; Domenica Ronchetti; Enrica Romeo; Maria Eugenia Gallo Cantafio; Debora Soncini; Lorenza Maltese; Marco Rossi; Aldo M Roccaro; Michele Cea; Pierfrancesco Tassone; Antonino Neri; Steven C Treon; Nikhil C Munshi; Giuseppe Viglietto; Nicola Amodio
Journal:  Exp Hematol Oncol       Date:  2022-09-12

Review 7.  G Protein-Coupled Estrogen Receptor in Cancer and Stromal Cells: Functions and Novel Therapeutic Perspectives.

Authors:  Richard A Pepermans; Geetanjali Sharma; Eric R Prossnitz
Journal:  Cells       Date:  2021-03-17       Impact factor: 6.600

Review 8.  Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers.

Authors:  Linda A Schuler; Fern E Murdoch
Journal:  Cancers (Basel)       Date:  2021-07-24       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.